The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
| Image |  |
|---|---|
| Description | scientific article published on 10 July 2021 |
| Author/s |
author: Dennis Kobelt Philipp Mertins Mathias Dahlmann Susen Burock Janice L Smith Rebekka Migotti Ulrike Stein Gunnar Dittmar |
| Publication date | July 10, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |